Acute Ischemic Stroke: Introduction to Diagnosis and Treatment

Slides:



Advertisements
Similar presentations
Stroke Workshop Case Scenario.
Advertisements

Some Difficult Stroke Cases: What Would You Do?
TPA… SMART or not SMART? That is the Question. Sarah Parker, MD.
Hyperacute Stroke Treatment: Inclusion and Exclusion Criteria
Disclosures: Maximo C. Kiok, M.D. Medical Director of Stroke Program Trinity Health System.
STROKESTROKESTROKESTROKE. Why Change? Improve Mortality Improve Mortality Devastating and Life Altering Devastating and Life Altering Cost expense of.
The cursor must be over the text in the question boxes to have the answers open correctly.
CLINICAL CASES.
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
Neuroimaging of Ischemic Stroke With CT and MRI
 Describe the major signs and symptoms of stroke  Classify stroke and type specific treatments  Apply 8 d’s of stroke care  Follow suspected stroke.
Acute ischemic stroke: Not a moment to lose By Julie Miller, RN, CCRN, BSN, & Janice Mink, RN, CCRN, CNRN Nursing2009, May ANCC contact hours.
Consultant Neurologist,
Stroke and the ED Kurian Thomas, MD Department of Neurology.
The Evolving Management of Pediatric Stroke Christopher A. Miller, MD July 21, 2012.
Overview of new acute stroke trials Shawna Cutting, MD, MS Rush University Medical Center June 9, 2015.
Treatment of Ischaemic Stroke The American Heart Association American Stroke Association Guidelines Stroke. 2007;38:
STROKE Lalith Sivanathan 2015 ADVANCED CONCEPTS IN EMERGENCY CARE (EMS 483)
Subarachnoid Hemorrhage. Etiology Spontaneous (primary) subarachnoid hemorrhage usually results from ruptured aneurysms. A congenital intracranial saccular.
Case 60 F with PMH HTN, DM, CVA presented to UNC ED CC: seizure. Per the daughter the pt was walking and all of a sudden fell and her whole body started.
Dr. Meg-angela Christi M. Amores
Kim, Sun-Yong, M.D. Department of Radiology Ajou University Hospital, Suwon, Korea AGGRESIVE MECHANICAL CLOT DISRUPTION FOR ACUTE ISCHEMIC STROKE WITH.
Cerebrovascular Disease Nicholas Cascone, PA-C. Stroke – general characteristics  3 rd most common cause of death in US  Higher incidence in men, blacks,
Dr Payam Sasannejad, Neurologist Assistant Professor of mums Intravenous thrombolytic therapy in acute ischemic stroke.
Rikki Weems, PGY III August 20, 2015
Stroke Care: A Nursing Perspective BY: LESLIE CAMPBELL, RN & HILLARY MCCOY, RN, SCRN.
Stroke Rami Unterman, M.D.. Objectives Define and differentiate the types of stroke Recognize the urgency involved in the evaluation and management of.
Simon Howard Medical Management of Acute Stroke. Fast Recognition of Stroke With sudden onset neurological symptoms: 'FAST' should be used to screen for.
ACUTE STROKE TREATMENT: An introduction Dec.2014
Stroke Protocol Time Lost Is Brain Lost!. Objective: Improve patient care & outcomes Offer a standard of care Increase efficiency Meet accreditation recommendations.
Adult Stroke 2010 AHA Guidelines for CPR and ECC
Outpatient DVT assessment & treatment Daniel Gilada.
Management of Acute ISCHEMIC stroke
Acute Care of Ischemic Stroke
Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right side residual weakness, atrial fibrillation, currently.
Advances in Treatment for Acute Stroke
Methodist LeBonheur Healthcare
Treating Acute Ischemic Stroke, Can We Open Up the Time Window?
ACUTE ISCHEMIC STROKE Olajide Williams, MD MS.
Neuroradiology of Stroke and Headaches
Cerebral Vascular Accident
Table 1: Table 2: Non Therapeutic Angiograms in Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment Does not Adversely Affect Patient.
Iwata T, Mori T, Tajiri H, Uesugi T, Nakazaki M
From: Intra-arterial Prourokinase for Acute Ischemic StrokeThe PROACT II Study: A Randomized Controlled Trial JAMA. 1999;282(21): doi: /jama
Rapid Reversal of Warfarin Therapy in Patients with Intracranial / Intraspinal Bleeding Mount Auburn Hospital Blood Bank, Emergency Department, Critical.
Thrombectomy in Acute Stroke
Sameer A. Ansari, MD, PhD Associate Professor
Acute Stroke Therapy with IV Thrombolysis Lawrence R. Wechsler, M.D.
A Comparison of RE-LY and ROCKET AF Trial Designs and Outcomes
Cardiovascular Research Technology Conference (CRT 17)
When Not to Intervene in Acute Stroke or
Anticoagulation in Atrial Fibrillation
Use of NOACs is contraindicated for AF patients with mechanical prosthetic valves or moderate- severe mitral stenosis (usually of rheumatic origin). Although.
Setareh Omran, MD Vascular Neurology Fellow
Stroke Niazy B Hussam.
Update from education committee
Intern Morning Report July 2014 Tram Le, PGY3
Performance Improvement: Emergency Management in Acute Cerebrovascular Patients Current US Guidelines Lisa A. Shultz, MD Medical Director, Lourdes Stroke.
Approach to Hemorrhagic and Ischemic Strokes
Strokes.
Acute Ischemic Stroke First Eight Hours Dr. Mohammed Ateequr Rahman
Guidelines for Urgent Management of Stroke in Children
Modified Rankin score 0-2
The Role of Induced Hypertension and Hyperbaric Oxygen Therapy in Moyamoya Disease: A Case Report Smeer Salam, MD; Lisa Pabst, MD; Sushil Lakhani, MD;
TIA/Stroke (1) C.L.I.P.S. Why do we care?
Extended Window Thrombectomy
Cerebrovascular disease
The Multi-arm Optimization of Stroke Thrombolysis (MOST) Trial
Update from education committee
Hypertensive Crisis Halmat M. Jaafar (MSc. Clinical pharmacy)
Presentation transcript:

Acute Ischemic Stroke: Introduction to Diagnosis and Treatment Charles Esenwa, MD Stroke Fellow, Neurology

Risk Factors Age Hypertension Atrial fibrillation Carotid stenosis Previous stroke Tobacco Diabetes Hypercholesterolemia Illicit drug use Hypercoagulable state

Blood Flow in Stroke Territory Cerebral tissues dysfunction relating to to 1) cerebral blood flow (CBF), 2) time from stroke onset and 3) distance from the core of the infarct. In the setting of an acute vascular occlusion, CBF in the vascular territory diminishes rapidly. The progression from ischemia to infarction is directly related to drop in CBF and the length of time the tissue is hypoperfused.

Types of stroke Figure 35-2 shows the Trial of Org10172 in Acute Stroke Treatment (TOAST) classification criteria for ischemic stroke and the estimated relative distribution of stroke within each category

Netter, Neuroanatomy

Middle Cerebral Artery Haines – Neuroanatomy

Large Vessel Stroke Syndromes Emergency Neurology: Acute Stroke Management. 2012

Inpatient vs Outpatient Work Up ???

Goals in Acute Hospital Care Time to Treatment Therapy revascularization rate complication rate practicality and cost Neuroprotection extending viability of penumbra limiting long term effects of ischemia Patient Selection stroke type collaterals and penumbra prognotic factors co-morbidities Goal

IV TPA exclusion Contraindications In patients that are considered for alteplase/rtPA within the 0-3 hour window, the following exclusions apply:  Significant head trauma or prior stroke in previous 3 months  Symptoms suggest subarachnoid hemorrhage  Arterial puncture at non-compressible site in previous 7 days  Intracranial malignant neoplasm, arteriovenous malformation, or aneurysm  Recent intracranial or intraspinal surgery  Elevated blood pressure (systolic > 185 mmHg or diastolic > 110 mmHg) that is unable to be controlled  Active internal bleeding  Acute bleeding diathesis, including but not limited to platelet count < 100,000/mm³  Heparin received within 48 hours resulting in abnormally elevated aPTT, greater than the upper limit of normal  Current use of anticoagulant with INR > 1.7 or PT > 15 seconds  Current use of direct thrombin inhibitors or direct factor Xa inhibitors with elevated sensitive laboratory tests (such as aPTT, INR, platelet count, and ECT; TT, or appropriate factor Xa activity assays.) With respect to the oral agents, may consider alteplase/rtPA if there is clear evidence that the patient meets all three criteria: 1. Normal renal function (creatinine clearance > 50 mL/min), 2. Has not taken dabigatran, rivaroxaban or apixaban for at least the past 48 hours, and

Evidence for IV-TPA NINDS, NEJM 1995: TPA within 3hours of symptoms onset no change on NIHSS at 24hrs but better functional outcome at 3 months (absolute 12%, relative 30%) ECASS3, NEJM 2008: TPA within 4.5 hours of symptom onset ARR = 13%, RR = 30% ARR = 7%, RR = 15%

Why Intra-arterial Thrombectomy Calgary stroke program (Bhatia, et al, 2010)2 Analyzed CT-A database from 2002-2009 for patients with proximal occlusions who received tPA (n=127) Only 27 patients (21.25%) recanalized 1/24 distal ICA (4.4%) 21/65 M1 occlusions (32.3%) 4/13 M2 occlusions (30.8%) 1/25 basilar occlusions (4%) Recanalization was strongest predictor of good outcome

Endovascular therapy Includes: Indicated for large vessel occlusion Mechanical thrombectomy Intra-arterial TPA (IA-TPA) Indicated for large vessel occlusion Up to 6 hours from symptom onset Can use those when IV-TPA is contraindicated No Very clear evidence for benefit over IV-TPA

Time to Treament Saver, Oct 2016

Post Emergency Room Management ALL Stroke Patients Examine and complete NIHSS Re-evaluate airway Dysphagia Screen Consider duatube Venodynes EKG, serial troponins, telemetry, TTE HgA1C, Lipids, TSH, ESR/CRP, RPR, Utox, UA, U culture TPA not administered BP goal <220/120 *Aspirin (PO or rectal) *Lovenox (heparin if GFR<30) for DVT ppx TPA administered prior to NICU arrival BP goal <180/105 x24 hours Repeat head CT 24 hours post-TPA *Contraindicated x24hrs after TPA dosing  

Major Complications of Stroke Hemorrhagic conversion (2% without vs. 6% with TPA) Angioedema and anaphylaxis Cerebral Edema Myocardial infarction Respiratory failure Aspiration Pneumonia DVT/PE

Acute Stroke Case

Early Infarct Signs

ASPECTS SCORE 0-10 (10 being best)

Case Continued

Case Continued low CBV, prolonged MTT and decreased CBF, surrounded by a widespread area of tissue at risk; defined by relatively stable CBV, prolonged MTT and decreased CBF.

Case #2

Large Vessel Atherosclerosis

Case #3

Anti-platelet therapy

Case #4

Atrial Fibrillation

Clinical Cases Case 1 45 yo M with DM, HTN, HL and two previous strokes without residual deficit presents with acute dizziness, nausea/vomitting, diplopia and unsteadiness In the ED, NIHSS was 6 for weakness, ataxia and slurred speech

Case 1

Case 1: What are you worried about? How do you manage this case?

Case 2 53 yo M presented with sudden onset LOC. On exam he was unresponsive with extensor posturing throughout. Pupils were equal, oculocephalic reflex was absent, corneals were sluggish and he did not gag. NIHSS 30

Case 2: What is the syndrome What are the management issues? What could have been done to try to prevent this?

Case 3: 85 yo Woman with HTN and DMII, presented with acute aphasia and R sided weakness starting 20 minutes ago. NIHSS 17. Got IV-TPA within 1 hour of symptom onset.

Case 3: What is the syndrome? What is your BP goal? What do you worry about?

Case 3: On re-examination you note that her BP is 200/110 and NIHSS is now 24 Her nurse also tells you that she is concerned about her breathing. What do you to do next?

Case 3

Case 4: A 50 yo M presents with sudden onset L sided weakness and slurred speech. On examine she has a R gaze preference, neglects the L side and is not moving the left at all. NIHSS 20.

Case 4 What do you worry about?

MR angiogram

Case 4: Revisited What if he were fluctuating? Between NIHSS of 3 and NIHSS of 20 and has this scan?

Case 4: Revisited CT angiogram of the head

Case 4: Revisited MRI – DWI What can you do to further evaluate? How would you manage the blood pressure?

Trials

Trials